CARE Ratings FY26 Revenue Up 17.59% to ₹473 Cr, PAT Rises 24.07%

BANKINGFINANCE
Whalesbook Corporate News Logo
AuthorKavya Nair|Published at:
CARE Ratings FY26 Revenue Up 17.59% to ₹473 Cr, PAT Rises 24.07%
Overview

CARE Ratings reported a strong fiscal year 2025-26 with consolidated revenue up 17.59% to ₹473.07 crore and PAT increasing 24.07% to ₹173.70 crore. The company also recommended a dividend of ₹14 per share.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

CARE Ratings Reports Robust FY26 Growth

Consolidated Revenue: ₹473.07 crore
Consolidated PAT: ₹173.70 crore

Reader Takeaway: Strong double-digit growth in revenue and profit with a focus on technology and international expansion.

What just happened

CARE Ratings Ltd announced its financial results for the fiscal year 2025-26. The company reported a consolidated revenue of ₹473.07 crore, marking a 17.59% increase compared to ₹402.32 crore in the previous fiscal year. Consolidated Profit After Tax (PAT) grew by 24.07% to ₹173.70 crore from ₹140.01 crore.

Why this matters

The strong financial performance indicates CARE Ratings' ability to grow its top and bottom lines effectively. The increase in PAT outpacing revenue growth suggests improved operational efficiency and profitability. The recommended dividend of ₹14 per share signals confidence in future performance and a commitment to shareholder returns.

The backstory

The company has been focusing on a strategy of 'Quality-Led Growth', emphasizing analytical rigor and independence. CARE Ratings has been integrating advanced technologies like AI and machine learning through its platform EdgeAvira.ai. Furthermore, its international arm, CareEdge Global IFSC, has completed its first full year, expanding its reach in sovereign ratings.

What changes now

Investors can expect the company to continue its focus on technological advancements and international market penetration. The robust performance may lead to sustained investor confidence, provided the company effectively navigates upcoming challenges.

Risks to watch

Management remains watchful of macroeconomic risks, including geopolitical tensions and potential trade policy shifts, which could impact capital flows and corporate investment. Additionally, any significant changes in RBI regulations, particularly concerning internal ratings-based approaches, could influence the demand for credit rating services.

Peer comparison

CARE Ratings maintains a significant market share of 58% in the Category 1 Issuer-pays ESG ratings segment, demonstrating a strong competitive position in a growing niche.

Context metrics (time-bound)

For FY 2025-26, CARE Ratings reported consolidated revenue of ₹473.07 crore, up 17.59% YoY. PAT stood at ₹173.70 crore, a 24.07% YoY increase. EBITDA was ₹197.40 crore, up 27.08% YoY. Earnings Per Share (EPS) was ₹57.06.

What to track next

Investors should monitor the company's response to macroeconomic uncertainties and regulatory developments. Continued growth in ESG and sovereign ratings, along with successful technology integration, will be key indicators.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.